C9021 – Injection, obinutuzumab, 10 mg
HCPCS Level II code · C codes: Outpatient PPS (Hospital Outpatient)
HCPCS codeC9021
- Long description
- Injection, obinutuzumab, 10 mg
- Short description
- Injection, obinutuzumab
- Pricing indicator
53Statute- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1DChemotherapy- Added
- April 1, 2014
- Last change
- January 1, 2015 – No change
- Termination date
- December 31, 2014
Frequently asked questions
What is HCPCS code C9021?
C9021 is a HCPCS Level II code for injection, obinutuzumab, 10 mg. It was discontinued on December 31, 2014.
Does Medicare cover C9021?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby C codes
- C8934 – Magnetic resonance angiography with contrast, upper extremity
- C8935 – Magnetic resonance angiography without contrast, upper extremity
- C8936 – Magnetic resonance angiography without contrast followed by with contrast, upper extremity
- C8937 – Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure)
- C8957 – Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump
- C9014 – Injection, cerliponase alfa, 1 mg
- C9015 – Injection, c-1 esterase inhibitor (human), haegarda, 10 units
- C9016 – Injection, triptorelin extended release, 3.75 mg
- C9022 – Injection, elosulfase alfa, 1mg
- C9023 – Injection, testosterone undecanoate, 1 mg
- C9024 – Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
- C9025 – Injection, ramucirumab, 5 mg
- C9026 – Injection, vedolizumab, 1 mg
- C9027 – Injection, pembrolizumab, 1 mg
- C9028 – Injection, inotuzumab ozogamicin, 0.1 mg
- C9029 – Injection, guselkumab, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.